Clinical Trials & Research
As part of the comprehensive service that Southern Neurology provides, we also participate in investigator driven and industry sponsored clinical trials.
This provides our patients with the opportunity to have access to potential new therapies. In general, Southern Neurology is compensated by the pharmaceutical companies on a per-subject basis for each clinical trial to cover the costs of investigator time, ancillary personnel, facilities use, tests and procedures.
Below is a list of clinical trials that we are currently or imminently involved in as part of an international multi-centre collaboration. Generally, patients who wish to take part in these trials will need to be assessed and managed by one of our Neurologists to ensure that all inclusion criteria are met for the particular trial.
Please contact our Clinical Research Coordinators at clinical.trials@southern-neurology.com.au if you would like to find out more.
Browse the Research and related Publications by our Doctors here.
Featured care areas
We provide expert, patient-centred care for complex neurological conditions.
-
Southern Neurology is proud to be running multiple trials investigating potentially new medications for people suffering from Alzheimer’s Disease. Please complete the below form or email to find out more clinical.trials@southern-neurology.com.au
-
Southern Neurology is proud to be running multiple trials investigating potentially new medications for people suffering from Parkinson’s Disease. Please complete the below form or email to find out more clinical.trials@southern-neurology.com.au
-
Southern Neurology is proud to be running multiple trials investigating potentially new medications for people suffering from headache and migraine. Please complete the below form or email to find out more clinical.trials@southern-neurology.com.au
-
Multiple Sclerosis (relapsing-remitting, secondary progressive, primary progressive)
Southern Neurology is actively involved in clinical trials exploring new and emerging therapies for people living with Multiple Sclerosis, including relapsing-remitting, secondary progressive, and primary progressive MS.
Please complete the form below or email clinical.trials@southern-neurology.com.au to learn more about current research opportunities. -
Southern Neurology is proud to be running multiple trials investigating potentially new medications for people suffering from Myasthenia Gravis. Please complete the below form or email to find out more clinical.trials@southern-neurology.com.au
-
Southern Neurology is proud to be running multiple trials investigating potentially new medications for people suffering from Essential tremor. Please complete the below form or email to find out more clinical.trials@southern-neurology.com.au
-
Amyotrophic Lateral Sclerosis (ALS / Motor Neuron Disease)
Southern Neurology is actively involved in clinical trials exploring new and emerging therapies for people living with Amyotrophic Lateral Sclerosis (ALS), also known as Motor Neuron Disease.
Please complete the form below or email clinical.trials@southern-neurology.com.au to learn more about current research opportunities.
-
Southern Neurology is proud to be running multiple trials investigating potentially new medications for people suffering from epilepsy. Please complete the below form or email to find out more clinical.trials@southern-neurology.com.au
-
Southern Neurology is proud to be running multiple trials investigating potentially new medications for people suffering from seizure. Please complete the below form or email to find out more clinical.trials@southern-neurology.com.au
-
Stroke (acute, post-stroke recovery, secondary prevention)
Southern Neurology is proud to be running multiple trials investigating potentially new medications for people who have suffered a stroke. Please complete the below form or email to find out more clinical.trials@southern-neurology.com.au
-
Southern Neurology is actively involved in clinical trials exploring new and emerging therapies for people living with neuropathic pain.
Please complete the form below or email clinical.trials@southern-neurology.com.au to learn more about current research opportunities. -
Southern Neurology is actively involved in clinical trials exploring new and emerging therapies for people living with dystonia.
Please complete the form below or email clinical.trials@southern-neurology.com.au to learn more about current research opportunities. -
Southern Neurology is actively involved in clinical trials exploring new and emerging therapies for people living with Restless Legs Syndrome.
Please complete the form below or email clinical.trials@southern-neurology.com.au to learn more about current research opportunities. -
Southern Neurology is actively involved in clinical trials exploring new and emerging therapies for people living with trigeminal neuralgia.
Please complete the form below or email clinical.trials@southern-neurology.com.au to learn more about current research opportunities.
Studies open to recruitment
Alzheimer's Disease
MK-2214-004
A Phase 2 Randomized, Placebo-Controlled, Double-Blind, Parallel-Group Study to Evaluate the Efficacy and Safety of MK-2214 in Participants With Early Alzheimer's Disease
CN012-0051
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for the Treatment of Cognitive Impairment Associated With Mild to Moderate Alzheimer's Disease (MINDSET 1)
I9M-MC-ONAA
A Phase 1, Open Label, Multiple-Dose Study to Assess the Changes in Cerebrospinal Fluid Biomarkers for Alzheimer's Disease Following Treatment With LY3439539 in Participants With Symptomatic Alzheimer's Disease
Multiple Sclerosis
CLOU064P12301
A Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy and Safety of Remibrutinib in Patients With Secondary Progressive Multiple Sclerosis
BP46016
A Multi-center, Double-blind, Placebo-controlled, Phase II Study Evaluating the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of RO7268489, a Monoacylglycerol Lipase Inhibitor, as Add-on Therapy to Ocrelizumab, in Participants With Progressive Forms of Multiple Sclerosis
MRX-4TZT-05
A Multicenter, Randomized, Fixed Sequence, Cross-over Study to Assess the Safety, Tolerability, and Pharmacokinetics of MRX-4TZT TDS (Tizanidine Transdermal Delivery System) versus Oral Tizanidine in Multiple Sclerosis Patients with Established Spasticity
Parkinson's Disease
BN44715
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Intravenous Prasinezumab in Participants With Early-Stage Parkinson's Disease